These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15035903)

  • 1. Comments on "Mega-dose vitamins and minerals in the treatment of nonmetastatic breast cancer: an historical cohort study".
    Hoffer A
    Integr Cancer Ther; 2003 Jun; 2(2):155-7. PubMed ID: 15035903
    [No Abstract]   [Full Text] [Related]  

  • 2. Mega-dose vitamin and mineral therapy in breast cancer: a clinician's perspective.
    Block KI
    Integr Cancer Ther; 2003 Jun; 2(2):163-5. PubMed ID: 15035906
    [No Abstract]   [Full Text] [Related]  

  • 3. Mega-dose vitamins and breast cancer.
    Block KI; Gyllenhaal C
    Integr Cancer Ther; 2003 Jun; 2(2):145-6. PubMed ID: 15035901
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of hormone replacement therapy on postmenopausal breast cancer biology and survival.
    Keskek M; Ozalp N; Tez M
    Am J Surg; 2010 May; 199(5):723. PubMed ID: 20466120
    [No Abstract]   [Full Text] [Related]  

  • 5. Adjuvant clodronate in breast cancer.
    Paterson AH
    Acta Oncol; 2005; 44(1):80-2; author reply 83-4. PubMed ID: 15848910
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical testing of supplementation therapy in early stage breast cancer: pitfalls and opportunities.
    Tripathy D
    Integr Cancer Ther; 2003 Jun; 2(2):160-2. PubMed ID: 15035905
    [No Abstract]   [Full Text] [Related]  

  • 7. Lecithin supplements and breast cancer risk.
    Anderson LN; Cotterchio M; Boucher BA
    Epidemiology; 2011 May; 22(3):444-6. PubMed ID: 21464659
    [No Abstract]   [Full Text] [Related]  

  • 8. [Changing diagnosis and surgical treatment of breast cancer].
    Paajanen H
    Duodecim; 2005; 121(18):1983-9. PubMed ID: 16300313
    [No Abstract]   [Full Text] [Related]  

  • 9. Zoledronic acid significantly reduces skeletal complications compared with placebo in Japanese women with bone metastases from breast cancer: a randomized, placebo-controlled trial.
    Kohno N; Aogi K; Minami H; Nakamura S; Asaga T; Iino Y; Watanabe T; Goessl C; Ohashi Y; Takashima S
    J Clin Oncol; 2005 May; 23(15):3314-21. PubMed ID: 15738536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The SU.VI.MAX trial on antioxidants.
    Hercberg S; Galan P; Preziosi P; Malvy M; Briançon S; Ait HM; Rahim B; Favier A
    IARC Sci Publ; 2002; 156():451-5. PubMed ID: 12484233
    [No Abstract]   [Full Text] [Related]  

  • 11. Mega-dose vitamins and minerals in the treatment of non-metastatic breast cancer: an historical cohort study.
    Lesperance ML; Olivotto IA; Forde N; Zhao Y; Speers C; Foster H; Tsao M; MacPherson N; Hoffer A
    Breast Cancer Res Treat; 2002 Nov; 76(2):137-43. PubMed ID: 12452451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating the correlation between hospital of primary treatment and the survival of women with breast cancer.
    Hébert-Croteau N; Brisson J; Lemaire J; Latreille J; Pineault R
    Cancer; 2005 Oct; 104(7):1343-8. PubMed ID: 16080144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant chemotherapy in stage III breast cancer.
    Alassas M; Chu Q; Burton G; Ampil F; Mizell J; Li BD
    Am Surg; 2005 Jun; 71(6):487-92. PubMed ID: 16044927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do biomarker changes during neoadjuvant endocrine therapy reflect breast tumor receptor status?
    Dickler M
    Nat Clin Pract Oncol; 2005 Oct; 2(10):498-9. PubMed ID: 16205767
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma carotenoids and recurrence-free survival in women with a history of breast cancer.
    Rock CL; Flatt SW; Natarajan L; Thomson CA; Bardwell WA; Newman VA; Hollenbach KA; Jones L; Caan BJ; Pierce JP
    J Clin Oncol; 2005 Sep; 23(27):6631-8. PubMed ID: 16170170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-year follow-up after sentinel node mapping for breast cancer demonstrates better than expected treatment outcomes.
    Fuhrman GM; Gambino J; Bolton JS; Farr G; Jiang X
    Am Surg; 2005 Jul; 71(7):564-9; discussion 569-70. PubMed ID: 16089119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does stage at diagnosis explain the difference in survival after breast cancer in Denmark and Sweden?
    Jensen AR; Garne JP; Storm HH; Engholm G; Möller T; Overgaard J
    Acta Oncol; 2004; 43(8):719-26. PubMed ID: 15764216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of aromatase inhibitors in postmenopausal women with hormone receptor positive breast cancer.
    Benson JR
    J Clin Oncol; 2005 Sep; 23(27):6807-9. PubMed ID: 16170197
    [No Abstract]   [Full Text] [Related]  

  • 19. Radiation pneumonitis in breast cancer patients treated with taxanes: does sequential radiation therapy lower the risk?
    Beal K; Hudis C; Norton L; Wagman R; McCormick B
    Breast J; 2005; 11(5):317-20. PubMed ID: 16174151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endostatin gene variation and protein levels in breast cancer susceptibility and severity.
    Balasubramanian SP; Cross SS; Globe J; Cox A; Brown NJ; Reed MW
    BMC Cancer; 2007 Jun; 7():107. PubMed ID: 17587451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.